R

RareCyte, Inc.

66 employees

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

Basic info

Industry

biotechnology research

Sectors

spatial biology
Biotechnology
Medical Device
IF microscopy
Liquid Biopsy
Circulating Tumor Cell Research
rare cell retrieval
Immuno-oncology
Single cell analysis
oncology
Health Diagnostics
Health Care
rare cell isolation
cell and gene therapy
tissue micro-region retrieval
Biomarkers
clinical trials
NIPT
Rare Cell Analysis
tissue IF and H&E imaging
Non-Invasive Prenatal Testing Research

Date founded

2009

Funding rounds raised

Total raised

$30M

from 10 investors over 10 rounds

R

RareCyte, Inc. raised undisclosed on November 3, 2022

Investors: Gastro-Intestinal Research Foundation

R

RareCyte, Inc. raised $24M on September 9, 2021

Investors: HealthQuest Capital, 5AM Ventures, F-Prime Capital Partners and Logos Global Management, LP

R

RareCyte, Inc. raised $22M on December 19, 2019

Investors: 5AM Ventures and HealthQuest Capital

R

RareCyte, Inc. raised $30M on August 29, 2017

Investors: Telegraph Hill Partners and 5AM Ventures

R

RareCyte, Inc. raised undisclosed on August 21, 2012

Investors: Telegraph Hill Partners

FAQ